ArticleClinical rheumatology2026
Characteristic clinical and immunologic features of Sjögren's disease patients presenting with major salivary gland swelling at diagnosis.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION/
objectivesSjögren's disease (SjD) is a heterogeneous systemic autoimmune disorder with diverse clinical presentations. While sicca symptoms are considered hallmark features, a substantial proportion of patients present with non-sicca manifestations. Although major salivary gland swelling is a recognized feature, its potential implications for baseline evaluation and clinical characterization at diagnosis remain incompletely understood. We aimed to classify SjD patients according to presenting symptoms at diagnosis and to characterize the clinical features of patients presenting with major salivary gland swelling.
methodWe conducted a retrospective observational study of patients with SjD who were enrolled at a tertiary referral center between June 2020 and March 2025. Patients were categorized by the predominant presenting symptom documented at diagnosis. Baseline clinical indices, imaging, laboratory findings, and treatment status were assessed at cohort enrollment. Clinical features were compared between patients presenting with major salivary gland swelling and those with other presenting symptoms.
resultsAmong 731 patients with SjD, major salivary gland swelling was the presenting symptom at diagnosis in 48 (6.6%). These patients were significantly younger at diagnosis and had higher objective disease activity despite comparable patient-reported symptom burden. Salivary gland ultrasonography demonstrated more severe abnormalities. Lymphadenopathy, hypergammaglobulinemia, and low C3 levels were more frequent. In multivariable analysis, younger age and low C3 remained independently associated with major salivary gland swelling presentation.
conclusionsMajor salivary gland swelling as a presenting symptom at diagnosis was associated with a distinct SjD phenotype. Recognition of this presentation may support a more comprehensive baseline clinical and immunologic evaluation. Key Points • Major salivary gland swelling as a presenting symptom represents a clinically meaningful phenotype of Sjögren's disease. • This phenotype is characterized by younger age, higher systemic disease activity, and more severe ultrasonographic glandular involvement. • Recognition of this presentation may support a more comprehensive baseline clinical and immunologic evaluation.
Indexed as
Identifiers
42702704What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.